Stem cell therapy shows early promise: Celgene

Crohn’s disease is a favorite amongst mesenchymal stem cell development companies. This may be because on the one hand, this type of stem cell possesses anti-inflammatory properties, and on the other hand it has the potential to regenerate injured tissue. Additionally since the quality of life of patients with advanced Crohn’s Disease is so poor,…